Home About Us Contact Us

 

Table of Content - Volume 13 Issue 2 -February 2020



Haemodynamic Response to Laryngoscopy and Intubation After Preoxygenation with Nitrous Oxide: Randomized Clinical Trial

 

Prasanth Mohan1*, Sarath V K Pillai2, Sunil Rajan3

 

1Assistant Professor, Department of Anaesthesiology, Sreenarayana Institute of Medical Sciences, Chalakka, Ernakulam

2Consultant, Department of Anaesthesiology, Aster MIMS hospial, Chala, Kannur

3Professor, Dept. of Anaesthesiology, Amrita Institute of Medical Sciences, Edapally, Ernakulam

Email: kannan345@gmail.com

 

Abstract               Background: Nitrous oxide inhalation significantly reduces the induction dose of propofol and also can prevent the hypotension and bradycardia accompanying propofol induction. Aim: To study the effect of pre-induction inhalation of nitrous oxide on haemodynamic parameters during laryngoscopy and intubation. Material and Methods: Patients were randomly divided into two equal groups by closed envelope technique to Group A and group B. Group A: received incremental doses of propofol following nitrous oxide inhalation for 3 minutes, pre-oxygenated with 4 litres/minute nitrous oxide and 2 litres/minute of oxygen. Group B: received only propofol as induction agent, inhaled with pre-oxygenated with 6 litres/minute of oxygen for 3 minutes with a tight fitting face mask. Pulse rate, systolic blood pressure, diastolic blood pressure and mean arterial pressure of each patient were measured at pre-inducstion and different intervals. Results: Mean systolic blood pressure at pre-induction in Group A was 133.39±13.734 and in Group B was 125.14±20.526. The diastolic pressures decreased in both Groups post induction, but the fall in these pressures was more in Group B than in Group A. The decrease in MAP was more in Group B than in group A and showed a significant difference when compared. Conclusion: Inhaling 66% nitrous oxide for 3 minutes before induction prevented a precipitous fall in mean arterial pressure at induction and effectively attenuated stress response to laryngoscopy and intubation without desaturation.

Key Word: Laryngoscopy, Intubation, Nitrous oxide, pre-oxygenation, haemodynamic response

 

 

INTRODUCTION

Nitrous oxide, one of the oldest and still popular anaesthetic gas has been a cornerstone in anaesthetic practice since its first use in 1840’s. Though, a poor anaesthetic agent, it has good analgesic properties. It is usually used as an adjuvant and a vehicle for the administration of more potent volatile anaesthetics. Nitrous oxide decreases the minimum alveolar concentration (MAC)1 required for volatile anaesthetics and also decreases the need for intravenous (IV) anaesthestics.2-4 Propofol nowadays has become a commonly used intravenous anaesthetic agent as it provides faster onset of action, antiemesis, rapid recovery, potent attenuation of pharyngeal and laryngeal reflexes and adequate depth of anaesthesia during intubation. So, it is considered the newer age anaesthetic agent, which got rapidly accepted worldwide as an almost ideal induction agent. Hence, it is increasingly being used for induction and maintenance of anaesthesia and for sedation in and outside the operating room.5The major disadvantages of propofol induction are the considerable decrements in arterial blood pressures,6-8 bradycardia9,10 and its high cost. When propofol is used alone, it produces hypotension and bradycardia at a dose when gives a good plane of anaesthesia for intubation. A fact which is commonly practiced in anaesthesia is that, using different drugs with similar actions can be combined to achieve a desired action, without reaching a toxic concentration of any of the drug. So, if nitrous oxide inhalation significantly reduces the induction dose of propofol, it will be advantageous as nitrous oxide is relatively cheaper compared to propofol and also can prevent the hypotension6-8 and bradycardia9,10 accompanying propofol induction. Hence, the present randomized clinical trial was conducted to study the effect of pre-induction inhalation of nitrous oxide on haemodynamic parameters during laryngoscopy and intubation.

 

MATERIAL AND METHODS

The present randomized clinical trial was conducted in a tertiary care hospital over a period of two years after obtaining permission from Institutional Ethical Committee.

Sample size

Sample size was based on the results obtained on the dose of propofol and induction time from the earlier publications11 and with 99% confidence and 99% power, minimum sample size came to 19 in each group. However, we recruited 152 patients in this randomized, prospective clinical trial.

Inclusion criteria

  • Age 20-60 years of either sex
  • Patients undergoing elective surgery under general anaesthesia with endotracheal intubation
  • ASA physical status I and II.

Exclusion criteria

  • Allergy to propofol.
  • Pregnant and lactating women.
  • Patients belonging to ASA III and above
  • Obesity, COPD, Bronchial asthma, Interstitial lung diseases
  • Uncontrolled hypertensives
  • Patient refusal

Patient groups

Patients were randomly divided into two equal groups by closed envelope technique to Group A and group B.

  • Group A: received incremental doses of propofol following nitrous oxide inhalation for 3 minutes, pre-oxygenated with 4 litres/minute nitrous oxide and 2 litres/minute of oxygen
  • Group B: received only propofol as induction agent, inhaled with pre-oxygenated with 6 litres/minute of oxygen for 3 minutes with a tight fitting face mask.

Methodology

In this study, all the patients were examined during the pre-operative visit. A detailed history was taken and a complete general physical examination performed. Routine investigations, as per the clinical scenario demands, were carried out and recorded. In the operation room a large bore IV access was started under local anaesthesia and patients were pre-medicated with intravenous glycoyrrolate 0.2mg and fentanyl 2mcg/kg. Patients in group A were asked to inhale 4 litres/minute nitrous oxide and 2 litres/minute of oxygen while patients in group B were pre-oxygenated with 6 litres/minute of oxygen for 3 minutes with a tight fitting face mask. Loss of response to verbal command (taking deep breaths/opening eyes) and no response to jaw thrust were taken as the end point of induction. Starting at the end of three minutes, after assessing response to verbal command and jaw thrust, both the groups were given propofol bolus 20 mg every minute intravenously. Induction time was calculated as time from start of propofol injection to loss of response to verbal command and jaw thrust, and induction dose as total amount of propofol administered till that time. After confirming the ability to mask ventilate, patients were given suxamethonium 2mg/kg and midazolam 1 mg intravenously and ventilated with same gas mixture plus isoflurane 1%. After one minute a quick and gentle laryngoscopy was done and patients were intubated with an appropriate sized endotracheal tube. Pulse rate, systolic blood pressure, diastolic blood pressure and mean arterial pressure of each patient were measured at preinduction, at induction,1, 3, 5, 10 and 15 min after induction. Desaturation was defined as SpO2<90% and if any patient developed desaturation during nitrous oxide inhalation, the patient was ventilated with 100% oxygen and the data was not used for statistical analysis.

Statistical analysis

Data analyzed using IBM SPSS statistics 20 software. All the continuous variables are presented are presented are presented as mean+/-SD and categorized variables are presented as percentage. To compare the averages of continuous variables between two groups (Group A and Group B) those following normal distribution, independent sample ’t’ test was used. The variables not following normal distribution Mann Whitney U test was used. Paired Sample T test was used for comparing the average parameters at different time periods (within groups). For comparing the categorical variables (Gender, ASA) between groups, Chi-square test was used. The p-value less than 0.05 was considered as statistically significant.


 RESULTS

The mean age in group A was 44.57±12.90 years while in Group B it was 43.04±12.85 years. The age comparison showed no significant difference in distribution among two groups. Thirty-nine males and thirty-six female patients were enrolled in group A, whereas thirty-four males and forty-three female patients were enrolled in group B. Mean weight in group A was 62.47±8.96 kgs while in Group B was 61.22±9.907kgs. The weight comparison showed no significant difference in distribution among two groups as the p-values was 0.417. Group A had forty-four ASA1 patients and thirty-one ASA 2 patients, while Group B had forty-three ASA 1 and thirty-four ASA 2 patients. The group comparison revealed no significant difference among two groups with regard to distribution of gender and ASA physical status as the p-values for gender comparison was 0.333 and for ASA comparison was 0.726, both >0.05.

 

Table 1: Patient characteristics in two groups

Characteristics

Group A

Group B

P value

Age (Mean± SD)

44.57±12.90

43.04±12.85

0.464

Sex (Male/Female)

39/36

34/43

0.333

Weight (Mean± SD)

62.47±8.961

61.22±9.907

0.417

ASA (I/II)

44/31

43/34

0.726

Group comparison of heart rates during various time intervals revealed no significant difference in its distribution as the p-values were more than 0.05.

 

Table 2: Comparison of heart rates among two groups

Time

Group A

Group B

p value

Mean ± SD

Mean ± SD

Pre-induction

78.85 ± 14.865

79.96 ± 13.100

0.627

Loss of response

75.79 ±13.873

80.26 ±15.818

0.066

1 min

82.65 ± 15.641

84.78 ± 13.426

0.370

3 min

80.44 ± 15.740

84.82 ± 15.224

0.83

5 min

78.28 ± 12.905

81.47 ± 12.816

0.129

10 min

77.23 ± 13.590

78.55 ± 13.610

0.559

15 min

75.92 ± 12.595

75.61 ± 12.545

0.880

Mean SBP at pre-induction in Group A was 133.39±13.734 and in Group B was 125.14±20.526. As there is significant difference in distribution of systolic blood pressure at pre-induction, a percent difference in systolic blood pressure at pre-induction from various time intervals are used and the comparison showed insignificant difference in the distribution of pre-induction values among two groups.

 

Table 3: Comparison of percent difference of systolic blood pressure at various time intervals from baseline values

Time

Group A

Group B

P-Value

Mean+/- SD

Mean+/-SD

Loss of response

-6.2455±15.06033

-5.52 ± 23.95

0.82

1 min

-6.24 ± 16.14

7.17 ± 24.35

0

3 min

-1.62 ± 15.200

-1.07 ± 24.54

0

5 min

17.69 ± 12.96

-6.29 ± 18.01

0

10 min

-18.48 ± 12.93

-7.31 ± 19.60

0

15 min

-14.18 ± 14.39

-9.00 ± 18.01

0.05

Group comparison of systolic blood pressures among two groups in various time intervals showed significant difference in its distribution at the time of pre-induction values, at the time of loss of verbal response (LOVR), at 5 minutes post-induction and at 10 minutes post-induction.It was also seen that when the percent difference of systolic blood pressures at various time interval with the pre-induction values were made there was significant difference in its distribution at one minute, three minutes, five minutes and ten minutes. Statistical analysis shows that the systolic blood pressures decreased post induction and at various time intervals in both groups. But the decrease in systolic blood pressure was seen more in Group A when compared with Group B.


Table 4: Comparison of diastolic blood pressures among two groups

Time

Group A

Group B

P value

Mean ± SD

Mean ± SD

Preinduction

82.03 ± 11.320

78.43 ± 12.785

0.066

Loss of response

79.24 ± 13.616

73.58 ± 15.873

0.020

1 min

80.48 ± 18.246

81.92 ± 15.766

0.603

3 min

74.48 ± 15.384

76.55 ± 15.827

0.410

5 min

69.75 ± 11.761

73.96 ± 12.311

0.033

10 min

69.21 ± 11.271

74.22 ± 12.942

0.012

15 min

73.56 ± 12.660

72.14 ± 12.232

0.484

Group comparison of diastolic blood pressures revealed significant difference in its distribution at the time of loss of verbal response, at 5 minutes and at 10 minutes. The variable seems to have no significant variation in its distribution at pre-induction, at one minute, 3minute and 15 minutes post induction as the P-values obtained after comparison was more than 0.05.

 

Table 5: Comparison of mean arterial pressures among two groups

Time

Group A

Group B

p value

Mean ± SD

Mean ± SD

Preinduction

99.39 ± 14.927

96.31 ± 20.136

0.288

Loss of response

94.51 ± 16.208

86.57 ± 15.467

0.002

1 min

94.88 ± 20.718

99.69 ± 19.930

0.147

3 min

89.03 ± 17.578

91.50 ± 18.401

0.387

5 min

83.09 ± 12.935

88.42 ± 14.600

0.019

10 min

82.12 ± 12.013

87.21 ± 13.225

0.014

15 min

86.72 ± 12.903

85. 92 ± 13.485

0.710

Distribution of mean arterial pressures among two groups showed significant variation in its distribution at the time of loss of verbal response, at 5 minutes and at 10 minutes post induction. Comparison at rest of time period shows no significant variation in its distribution as the p-value is more than 0.05.

Table 6: Comparison of oxygen saturation among two groups

Time

Group A

Group B

p value

Mean ± SD

Mean ± SD

Preinduction

99.87 ± 0.475

99.92 ± 0.270

0.887

Loss of response

99.96 ± 0.257

99.81 ± 0.460

0.004

1 min

99.79 ± 0.890

99.82 ± 0.421

0.135

3 min

99.85 ± 0.485

99.81 ± 0.430

0.518

5 min

99.891 ± 0.452

99.83 ± 0.571

0.298

10 min

99.89 ± 0.388

99.94 ± 0.296

0.482

15 min

99.85 ± 0.425

99.90 ± 0.347

0.549

Group comparison of the oxygen saturation among two groups showed no significant difference at various time intervals as the p-value was more than 0.05.

 

DISCUSSION

In anaesthesia practice, multiple inhaled and intravenous agents are used which potentiate the anaesthetic effects and enable the usage of lesser amounts of drugs, which will subsequently reduce complications. It has been documented that when used in conjunction, nitrous oxide decreases requirement of intravenous anaesthetic agents like thiopentone and propofol.2-4 Though in the west, there are moves to omit routine use of nitrous oxide, it still remains the most commonly used inhalation agent in developing countries. The future of nitrous oxide doesn’t seem to be bleak, mainly because of its cost effectiveness.  Hypotension6-8 is invariably associated with propofol induction, more so in aged people. Preloading with colloid12 or crystalloids is not very effective in preventing this hypotension, whereas, combining propofol with ketamine, or etomidate may prevent hypotension. Whether a reduction in induction dose of propofol, secondary to preinduction inhalation of nitrous oxide, could lead to an exaggerated stress response to laryngoscopy and intubation would be a natural concern. In the present study it was seen that nitrous oxide inhalation effectively suppressed the heart rate as well as the hypertensive responses, at the same time maintaining MAP at induction. Comparison of heart rates among two groups revealed no significant variation in its distribution among two groups. Heart rates remained same without much variation from the baseline in Group A than Group B. On comparing the systolic blood pressure among two groups the pre-induction or the baseline values showed significant variation among its distribution in two groups. Hence, to avoid error, a percent difference of systolic blood pressure from the baseline values was taken. The percent difference in systolic blood pressure from the baseline value when compared between the two groups showed significant difference. In both groups there were fall in systolic blood pressure post induction. Fall in blood pressure was more evident in Group A than in Group B. But during post intubation period the systolic blood pressure significantly rose in Group A while in Group B it was still below the pre-induction value. During rest of the time intervals systolic blood pressures remained below the pre-induction value. This is in agreement with the previous study done by Ng et al2 where propofol infusion was used and also with the results obtained by Karalapillai et al.3 It was seen that the mean arterial pressures decreased in both the groups at the time of loss of verbal response. The decrease in MAP was more in Group B than in group A and showed a significant difference when compared. Post intubation MAP rose in Group B while in Group A, MAP remained close to the value at the time of Loss of verbal response. Hence, with the use of nitrous oxide MAP was always maintained. In this aspect our method of using nitrous oxide prior to induction provided better haemodynamics response to laryngoscopy and intubation than in a study by Gore et al13 where even with high doses of propofol (2,5mg/kg and 3mg/kg), there was rise in mean arterial pressures following intubation. The diastolic pressures decreased in both Groups post induction, but the fall in these pressures was more in Group B than in Group A. Administration of full dose of propofol could be the reason for this exaggerated fall in blood pressure in control group. Another concern while adopting this technique of pre-induction inhalation of nitrous oxide could be desaturation. There was no desaturation observed at induction during the present study and saturations in both groups remained well within clinically acceptable limits (99.81±0.46% vs 99.96±0.26%). So if patients are chosen carefully, avoiding those with anticipated difficult airway and low cardiorespiratory reserve, the technique seems quite safe in experienced hands. As cost containment is a growing concern in the heath sector nowadays, the observation in our study that inhaling nitrous oxide for 3 min leads to a 70% reduction in induction dose of propofol should be paid attention.

 

CONCLUSION

It can be concluded that inhaling 66% nitrous oxide for 3 minutes before induction prevented a precipitous fall in mean arterial pressure at induction and effectively attenuated stress response to laryngoscopy and intubation without desaturation.

 

REFERENCES

  1. Eger EI, Lampe GH, Wauk LZ, Whitendale P, Cahaln MK, Donagan JH. Clinical pharmacology of nitrous oxide: an argument for its continued use. Anaesth Analg 1990;71;575-85.
  2. Ng JM, Hwang NC. Inhaling nitrous oxide reduces the induction dose requirements of propofol. Anaesth Analog 2000;90:1213-16.
  3. Karalapillai D, Leslie K, Umranikar A, Bjorksten AR. Nitrous oxide and anaesthetic requirement for loss of verbal response to command during propofol anaesthesia. Anaesth Analg 2006;102:1088-933.
  4. Johnson GW, St John Gray H. Nitrous oxide inhalation as an adjunct to intravenous induction of general anaesthesia with propofol for day surgery. Eur J Anaesthesiology.1997;14:295-9.
  5. Yokoe C, Hanamoto H, Boku A, Sugimura A, Kudo C, Niwa H. The effect of nitrous oxide inhalation on the hypotensive response to propofol: A randomized controlled trial. Oral surg Oral med Oral Pathol Oral Radiol 2013;4:80-6.
  6. Yamaura K, Hoka S, Okamoto H, Kandabashi T, Akiyoshi K, Takahashi S. Changes in left ventricular end diastolic area and end systolic wall stress and fractional area change during anaesthetic induction with propofol or thiamylal. J Anaesth 2000;14:138-42.
  7. Reich DL, Hossain S, Krol M, Baez B, Patel P, Bernstein A, Bodian CA. Predictors of hypotension after induction of general anaesthesia. Anaesth Analg 2005;101:622-8.
  8. Benson M, Junger A, Fuch C, Quinzio L, Bottger S, Hempelmann G. Use of an anaesthesia information management system(AIMS) to evaluate the physiologic effects of hypnotic agents used to induce anaesthesia. J Clin Monit Camput 2000;16:183-90.
  9. Clifford S, Deutschman, Andrew P, Harris, Lee A, Fleisher. Changes in heart rate variabilty under propofol anaesthesia: a possible explanation for propofol induced bradycardia. Anaesth Analg 1994;79:373-7.
  10. Tramer MR, Moore RA, McQuay HJ. Propofol and Bradycardia: causation, frequency and severity. Br J Anaesth 1997;78:642-51.
  11. Desai SP, Desai MS, Pandav CS. The discovery of modern anaesthesia- contributions of Davy, Clarke, long Walls and Morton. Ind J Anaesth 2007;51:472-8.
  12. Dhungana Y, Bhattarai BK, Bhadani UK, Biswas BK, Tripathi M. Prevention of hypotension during propofol induction: a comparison of preloading with 3.5% polymers of degraded gelatin (Haemaccel) and intravenous ephedrine. Nepal Med Coll J 2008;10:16-9.
  13. Gore MS, Harnagale KD. Evaluation of intubating conditions with varying doses of propofol without muscle relaxants. J Anaesthesiol Clin Pharmacol 2011;27:27-30.

Policy for Articles with Open Access
Authors who publish with MedPulse International Journal of Anesthesiology (Print ISSN:2579-0900) (Online ISSN: 2636-4654) agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.